According to Zen Score, the 3 best health information service stocks to buy right now are:
1. Progyny (NASDAQ:PGNY)
Progyny (NASDAQ:PGNY) is the top health information service stock with a Zen Score of 64, which is 39 points higher than the health information service industry average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -7.72% over the past year, overperforming other health information service stocks by 17 percentage points.
Progyny has an average 1 year
price target of $47.67, an upside of 48.22% from Progyny's current stock price of $32.16.
Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Progyny, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Simulations Plus (NASDAQ:SLP)
Simulations Plus (NASDAQ:SLP) is the second best health information service stock with a Zen Score of 55, which is 30 points higher than the health information service industry average of 25. It passed 21 out of 38 due diligence checks and has strong fundamentals. Simulations Plus has seen its stock return 18.69% over the past year, overperforming other health information service stocks by 43 percentage points.
Simulations Plus has an average 1 year
price target of $51.00, an upside of 6.23% from Simulations Plus's current stock price of $48.01.
Simulations Plus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Simulations Plus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Privia Health Group (NASDAQ:PRVA)
Privia Health Group (NASDAQ:PRVA) is the third best health information service stock with a Zen Score of 51, which is 26 points higher than the health information service industry average of 25. It passed 17 out of 33 due diligence checks and has strong fundamentals. Privia Health Group has seen its stock lose -36.99% over the past year, underperforming other health information service stocks by -13 percentage points.
Privia Health Group has an average 1 year
price target of $26.50, an upside of 40.51% from Privia Health Group's current stock price of $18.86.
Privia Health Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Privia Health Group, 50% have issued a Strong Buy rating, 30% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.